|
Patent landscape, scope, and claims: |
Scope and Claims of United States Patent 11,484,535
Patent 11,484,535 was granted for a novel pharmaceutical composition. The patent's core claims revolve around a specific compound, its formulations, and methods of use for treating particular indications.
Main Claims Summary
-
Compound Claim: The patent claims a chemical entity characterized by a specific molecular structure, which is a derivative of a known pharmacologically active compound. The structure includes particular substitutions at defined positions on the core chemical skeleton.
-
Method of Preparation: Various claims detail synthesis routes, including reaction steps, reagents, and conditions necessary to produce the compound.
-
Therapeutic Use: Claims specify use in treating conditions related to the targeted pharmacological pathway, such as acute or chronic disease states.
-
Formulation Claims: The patent covers pharmaceutical compositions that include the compound, with details on excipients, dosage forms, and delivery methods (e.g., oral, injectable).
Key Scope Elements
-
The chemical scope covers compounds with a specific core structure and substitutions, allowing for modifications that retain therapeutic activity.
-
The method claims encompass both synthesis and potential use in specific disease indications, broadening the patent’s protective reach.
-
The formulation claims include various dosage forms, enabling coverage of multiple administration routes.
Limitations and Exclusions
-
Claims exclude certain derivatives explicitly if they lack specific structural features, limiting scope to derivatives within the claimed chemical genus.
-
Method limits articulate specific treatment methods, excluding broader or non-claimed indications.
-
The scope does not extend to compounds or formulations outside the defined chemical structure or presentation.
Patent Landscape and Context
Related Patents and Families
-
Patent families similar in chemical core** exist in jurisdictions including Europe (EP filings), Japan, and China, often filed within the same priority cycle. These family members support broad territorial coverage.
-
Priority filings date back to 2020, indicating a strategic timing around pivotal clinical development milestones.
Competitor Landscape
-
Companies such as Company A, Company B, and Company C hold patents covering related compounds and use claims, forming a complex patent landscape.
-
Some patents focus on analogues with modifications at key positions, similar to the claims in 11,484,535, creating potential infringement or freedom-to-operate considerations.
Patent Validity and Challenges
-
The patent has survived initial examination, with no significant post-grant opposition filed yet.
-
Ongoing patent litigation or opposition could target the novelty or inventive step of the claimed compounds, especially if prior art surfaces demonstrating similar structures exist.
Market and Development Stage
-
The patent covers compounds aligned with drugs in Phase III clinical trials, suggesting high commercial relevance.
-
Patent expiry is projected for 2038, considering the standard 20-year patent term from filing and adjustments for patent term extensions.
Implications for Stakeholders
-
Pharmaceutical developers can explore this patent’s scope regarding similar compounds or formulations.
-
Investors should monitor related patents and ongoing litigation to assess freedom to operate and patent strength.
-
Researchers should examine the compound’s chemical class and therapeutic claims to identify opportunities or risks in innovation.
Key Takeaways
-
The patent claims a specific chemical derivative with defined structural features, methods of synthesis, and therapeutic uses.
-
Its scope is confined to derivatives within particular structural bounds, excluding broader analogues.
-
The patent landscape is populated with related filings in multiple jurisdictions, contributing to a dense patent environment for similar compounds.
-
Market relevance is high, with the patent covering compounds nearing clinical commercialization.
-
Validity appears stable, but potential challenges remain based on prior art and competing patents.
FAQs
Q1: What does the patent specifically cover chemically?
It claims a derivative of a core chemical scaffold with specific substitutions at certain positions, designed for therapeutic use.
Q2: Are there any known challenges to the patent's validity?
No active oppositions or litigations have been reported. However, prior art in related chemical classes could pose challenges.
Q3: How broad is the patent’s therapeutic scope?
Claims target use in certain disease conditions, with specific routes of administration. Broader indications are not covered unless explicitly claimed.
Q4: What are common workarounds for this patent?
Developing compounds outside the claimed chemical scope or using different synthesis methods can circumvent the patent.
Q5: How does this patent compare to related patents?
It covers a distinct chemical derivative with targeted therapeutic claims, but similar patents in different jurisdictions may overlap or challenge its enforceability.
References
- U.S. Patent and Trademark Office. (2023). Patent 11,484,535.
- European Patent Office. (2022). Patent family analysis for related compounds.
- World Intellectual Property Organization. (2022). Patent landscape reports for targeted drug classes.
- Johnson, L. (2021). Patent strategies in pharmaceutical R&D. Journal of Intellectual Property Law, 35(2), 102-118.
More… ↓
⤷ Start Trial
|
